Skip to main navigation Skip to search Skip to main content

Artificial Intelligence for Drug Design

  • East China University of Science and Technology
  • CAS - Shanghai Institute of Materia Medica
  • University of Chinese Academy of Sciences
  • Zhejiang University
  • ShanghaiTech University

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This book focuses on the application of artificial intelligence in drug research and development, particularly its growing role in evaluating interactions between biological targets and drug molecules and optimizing drug design pathways. It offers a comprehensive structure divided into four parts: fundamentals of AI algorithms, data foundations and representations, AI driven drug design, and program code. The book systematically introduces key AI methodologies, highlights essential biomedical data resources, and presents data mining approaches based on artificial intelligence. Following the workflow of drug R&D, each chapter explains the basic principles and challenges of specific drug design steps and then reviews the corresponding advances in AI algorithms, supplemented by cross-disciplinary application examples. Readers will gain a clear understanding of how AI integrates into and accelerates the drug development process while reducing associated risks and costs, making the book particularly valuable for researchers and technical professionals engaged in life sciences and pharmaceutical R&D.

Original languageEnglish
Title of host publicationCoresource 4
PublisherSpringer Nature
Pages1-916
Number of pages916
ISBN (Electronic)9789819525256
ISBN (Print)9789819525249
DOIs
StatePublished - 2025

Fingerprint

Dive into the research topics of 'Artificial Intelligence for Drug Design'. Together they form a unique fingerprint.

Cite this